InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.440
+0.010 (0.70%)
At close: Aug 1, 2025, 4:00 PM
1.470
+0.030 (2.08%)
After-hours: Aug 1, 2025, 6:43 PM EDT
InterCure Market Cap
InterCure has a market cap or net worth of $70.86 million as of August 1, 2025. Its market cap has decreased by -35.01% in one year.
Market Cap
70.86M
Enterprise Value
110.15M
1-Year Change
-35.01%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from $1.78M to $70.86M, an increase of 3,878.35%. That is a compound annual growth rate of 28.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 70.86M | -5.02% |
| Dec 31, 2024 | 74.61M | 27.32% |
| Dec 31, 2023 | 58.60M | -62.52% |
| Dec 29, 2022 | 156.35M | -47.90% |
| Dec 30, 2021 | 300.11M | 119.01% |
| Dec 31, 2020 | 137.03M | 17.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |